News | Radiology Business | August 10, 2023

Groups continue work to protect access to care as they protect patients from surprise medical bills 

Groups continue work to protect access to care as they protect patients from surprise medical bills

Getty Images


August 10, 2023 — The American College of Radiology (ACR), American College of Emergency Physicians (ACEP) and American Society of Anesthesiologists (ASA) applaud the Aug. 3 U.S. District Court for the Eastern District of Texas’ ruling that the government's exorbitant 600% fee increase to access the independent dispute resolution (IDR) process and its overly restrictive “batching” limitations violate federal law. The ruling does not impact the patient protections included in the No Surprises Act, which ACR, ACEP and ASA advocated for and continue to support, nor does it raise patient out-of-pocket costs. 

The court agreed with plaintiffs — the Texas Medical Association (TMA), the Texas Radiological Society and Houston Radiology Associated — that the government wrongly raised the fees to participate in the IDR process established to resolve out-of-network care billing disputes, and restricted providers’ ability to submit claims for similar services in “batches” without giving providers advance notice and an opportunity to comment. 

ACR, ACEP and ASA filed a joint amicus brief with the Texas court showing how fee guidance published Dec. 23 by the Centers for Medicare and Medicaid Services (CMS) is unworkable. Effective Jan. 1, 2023, CMS increased the non-refundable administrative fee to contest disputed insurer reimbursement from $50 to $350. This drastic increase precludes many providers — particularly radiologists — from participating as their billed services are routinely less than $350. 

In addition, interim final rules (IFR) published in October 2021 unreasonably limit the batching of claims for the IDR process to the same or similar service codes. This means that only claims for the same code billed to the same insurance plan within a 30-day period may be batched, further limiting IDR access. 

Physicians, who are forced to utilize the IDR process because of unreasonable insurance payments, are prevailing in the arbitrators’ decisions more than 70% of the time. The court’s ruling is an important step in ensuring that the dispute resolution system is accessible and fair, as envisioned by the law’s authors. 

Notably, the government has suspended the IDR process, effective immediately, because of this latest court decision. CMS termed this as an “Unplanned Outage.” Physicians now must await further government guidance on how to submit claims under the IDR process for reimbursement of services. 

ACR, ACEP and ASA stand ready to work with the federal government, patient groups and other stakeholders to find solutions that ensure a fair IDR process for out-of-network care payment that is sufficiently accessible, can ease growing case backlogs and will help safeguard patient access to care.  

The Texas case solely impacts the IDR process to determine provider payment for out-of-network care. 

For more information: www.acr.org 

 

Related CMS Content: 

ASTRO Issues Statement on MPFS Proposed Rule   

National Cancer Plan Details Goals and Strategies of Cancer Moonshot Program, Highlights Role of Imaging in Screening and Detection    

US Government Issues Final Rules for Surprise Billing    

CMS Withdraws Guidance on Surprise Billing, Out-of-Network Payment Disputes     

ACR Joins "No Surprises Act" Lawsuit to Protect Patient Care     

Major Medical Associations Ask Federal Court for Summary Judgement in No Surprises Lawsuit     

Radiation Oncologists Applaud Biden-Harris Administration's Renewed Commitment to Cancer Moonshot       

Racial/Ethnic Disparities Persist in Lung Cancer Screening Eligibility       

Primary Lung Cancers Detected by LDCT are at Lower Risk of Brain Metastases       

Physician and Patient Groups Call On CMS to Update Medicare Lung Cancer Screening Coverage       

USPSTF Expands Lung Cancer Screening Eligibility Thresholds        

Low-dose CT for Lung Cancer Screening: Benefit Outweighs Potential Harm       

Physician and Patient Groups Call On CMS to Update Medicare Lung Cancer Screening Coverage  


Related Content

News | Endoscopes

Oct. 22, 2025 — Fujifilm Healthcare Americas Corp. has launched its advanced endoscopy platform, the ELUXEO 8000 ...

Time October 23, 2025
arrow
News | X-Ray

Oct. 22, 2025 — Imaging technology company Adaptix has begun live imaging trials as part of a research program at the ...

Time October 22, 2025
arrow
News | Contrast Media

Oct. 21, 2025 — Subtle Medical, Inc., a provider of AI-powered medical imaging solutions, has announced positive ...

Time October 21, 2025
arrow
News | Artificial Intelligence

Oct. 20, 2025 — Viz.ai has launched of Viz Assist, a suite of autonomous AI agents that significantly enhance how care ...

Time October 20, 2025
arrow
News | Point-of-Care Ultrasound (POCUS)

Oct. 15, 2025 — GE HealthCare has announced the latest advancement in its Venue family of point-of-care ultrasound ...

Time October 16, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

September 24, 2025—According to the American Journal of Roentgenology (AJR), MRI can reliably identify lateral meniscal ...

Time October 03, 2025
arrow
News | Radiopharmaceuticals and Tracers

Oct. 01, 2025 – Nuclidium AG, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time October 02, 2025
arrow
News | Radiology Business | Harvey L. Neiman Health Policy Institute

Sept. 30, 2025 — A new study from the Harvey L. Neiman Health Policy Institute found that attrition (i.e., exit) from ...

Time October 02, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

Sept. 10, 2025 —GE HealthCare announced it has entered into an agreement to acquire icometrix, a company focused on ...

Time September 10, 2025
arrow
News | Lung Imaging

Sept. 4, 2025 — Sentec recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...

Time September 08, 2025
arrow
Subscribe Now